Foghorn Therapeutics Inc.
FHTX
$6.26
-$0.23-3.54%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 167.58M | 183.63M | 158.89M | 180.28M | 198.67M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.46M | 3.18M | 3.09M | 2.59M | 3.93M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 1.25M | 1.25M | 1.25M | 1.25M |
| Total Current Assets | 170.05M | 188.06M | 163.24M | 184.12M | 203.84M |
|
|
|||||
| Total Current Assets | 170.05M | 188.06M | 163.24M | 184.12M | 203.84M |
| Net Property, Plant & Equipment | 31.34M | 32.10M | 32.86M | 18.84M | 20.39M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.00M | 2.00M | 2.00M | 2.01M | 2.01M |
| Total Assets | 203.39M | 222.17M | 198.10M | 204.96M | 226.24M |
|
|
|||||
| Total Accounts Payable | 3.21M | 3.32M | 4.27M | 3.21M | 3.32M |
| Total Accrued Expenses | 7.96M | 6.92M | 11.36M | 9.82M | 8.56M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.82M | 1.86M | 923.00K | 6.76M | 6.18M |
| Total Finance Division Other Current Liabilities | 36.59M | 52.30M | 43.19M | 65.30M | 59.72M |
| Total Other Current Liabilities | 36.59M | 52.30M | 43.19M | 65.30M | 59.72M |
| Total Current Liabilities | 50.58M | 64.40M | 59.74M | 85.09M | 77.79M |
|
|
|||||
| Total Current Liabilities | 50.58M | 64.40M | 59.74M | 85.09M | 77.79M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 40.28M | 40.13M | 40.35M | 15.77M | 17.52M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 193.57M | 194.04M | 206.52M | 193.76M | 207.59M |
| Total Liabilities | 284.43M | 298.58M | 306.60M | 294.62M | 302.90M |
|
|
|||||
| Common Stock & APIC | 578.63M | 576.07M | 523.94M | 521.12M | 518.34M |
| Retained Earnings | -659.53M | -652.34M | -632.47M | -610.80M | -594.95M |
| Treasury Stock & Other | -134.00K | -133.00K | 24.00K | 24.00K | -44.00K |
| Total Common Equity | -81.04M | -76.41M | -108.50M | -89.66M | -76.66M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -81.04M | -76.41M | -108.50M | -89.66M | -76.66M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -81.04M | -76.41M | -108.50M | -89.66M | -76.66M |
|
|
|||||